AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

China’s stock market has long been more volatile than Beijing would like, a problem that has taken on greater urgency as the ...

Bridgewater Associates said it is still bullish on Chinese stocks this year, after the local market’s rally helped its ...

Silver wiped out most of its meteoric price gains this year that was in part driven by Chinese demand.

Reuters reported that China has approved sales of Nvidia's H200, sending the AI chip giant's shares higher in premarket trade ...

China's bold policy changes and booming tech sectors are creating fresh momentum for U.S.-listed Chinese companies like Tencent Holdings TCEHY, Bilibili BILI, and Baidu BIDU, as Beijing prepares for ...

A detailed analysis shows that UNH’s substantial scale and profitability are evident in its strong operating and free cash flow (FCF) ...

Nvidia previously pegged lost China revenue at $8 billion a quarter, and that was for a scaled-down chip Nvidia CEO Jensen Huang recently lamented pressure from both the U.S. and China, which has ...

China approved 400,000 Nvidia H200 chips at a 25% tariff—the silicon surrender validates Nvidia's foundational position.

The latest twist in Nvidia’s China saga? President Donald Trump’s new post saying that he’ll allow chip sales to China as long as the U.S. government gets a 25% cut of business. Trump first teased an ...